Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth [Phase 3]
Phase 3 clinical trial update on weight loss in Parkinson's disease and the role of small bowel bacterial overgrowth. Results have been post…
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET Scan [NA]
A clinical trial aims to predict dementia in Parkinson's disease by measuring cerebral metabolism with PET imaging; the study status is curr…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Diagnosis of Parkinson's Disease Using Diffusion Magnetic Resonance Imaging
A completed clinical trial evaluated diffusion magnetic resonance imaging as a diagnostic tool for Parkinson's disease. The study was sponso…
-
CLINICAL_TRIALS research · 2016-08-02Clinical Trial Update: Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease [Phase 1, Phase 2]
This clinical trial update discusses the investigation of thoracic spinal cord stimulation as a symptomatic treatment for advanced Parkinson…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: The Effect of a Motor-cognitive Rehabilitation on Attention in Parkinsonian Patients [NA]
A completed clinical trial assessing the effect of motor-cognitive rehabilitation on attention in patients with Parkinson's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664) [Phase 3]
Phase 3 trial of preladenant in early Parkinson's disease was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: The Electrophysiological Investigation of Higher Level Neural Manifestations of Freezing of Gait in Parkinson's Disease Patient [NA]
A completed clinical trial evaluating electrophysiological aspects of higher-level neural manifestations of freezing of gait in Parkinson's …
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550) [Phase 1]
Phase 1 trial update evaluating acute effects of preladenant (SCH 420814) on dyskinesia and parkinsonism in levodopa-treated participants wi…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact [Phase 4]
Phase 4 long-term study of Duodopa (levodopa/carbidopa) in advanced Parkinson's disease reports health outcomes and net economic impact; res…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients [Phase 2]
Phase 2 trial update evaluating two multiple-dose regimens of BIA 3-202 on the pharmacokinetics and motor response to Levodopa, and on eryth…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) [Phase 3]
This entry documents a completed Phase 3 safety study of AVP-923 for involuntary emotional expression disorder (pseudobulbar affect). It inv…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: SAM-e for the Treatment of Depression in Patients With Parkinson's Disease [Phase 2, Phase 3]
Clinical trial update reporting completed Phase 2 and Phase 3 results for SAM-e in treating depression in patients with Parkinson's disease;…
-
CLINICAL_TRIALS research · 2016-07-13Clinical Trial Update: Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease [NA]
This clinical trial update discusses clock- and narcolepsy-related genetic variants and their potential relevance to sleep disorders in Park…
-
CLINICAL_TRIALS research · 2016-07-11Clinical Trial Update: Telemedicine Program in Parkinson's Disease (TELEPARK) [NA]
Clinical trial update for the Telemedicine Program in Parkinson's Disease (TELEPARK) sponsored by Fondazione Salvatore Maugeri. The status o…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease
This clinical trial update reports results from a completed study evaluating the combination of rotigotine (Neupro) and L-dopa in patients w…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Evaluation of Behaviour in Parkinson's Disease. Normal Values in Healthy Subjects [NA]
A completed clinical trial update examining behavioral outcomes in Parkinson's disease and establishing normal behavioral values in healthy …
-
CLINICAL_TRIALS research · 2016-06-28Clinical Trial Update: Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease [NA]
This clinical trial update describes an ongoing study evaluating a personalized physical activity coaching program for Parkinson's disease. …
-
CLINICAL_TRIALS research · 2016-06-27Clinical Trial Update: Cannabis and Parkinson's Disease Tremor: A Natural History Study
A completed observational natural history study examining cannabis use and tremor in Parkinson's disease.
-
FDA approval · 2016-06-24FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Pramipexole dihydrochloride from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Phase IIb Study of Intranasal Glutathione in Parkinson's Disease [Phase 2]
A Phase IIb trial evaluating intranasal glutathione for Parkinson's disease has completed.
-
FDA approval · 2016-06-24FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals' pramipexole dihydrochloride as an original generic application, enabling a generic version of pramipe…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Efficacy of Pattern Respiratory PNF Associated Aerobic Training on Lung Volumes and 6MWT Test in Parkinson Individuals [NA]
This update reports on the efficacy of Pattern Respiratory PNF–associated aerobic training for improving lung volumes and the 6-minute walk …
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Lateral Postural Inclination in Parkinson's Disease : Involvement of the Basal Ganglia ? [NA]
The clinical trial NCT02704910 on lateral postural inclination in Parkinson's disease, sponsored by University Hospital Grenoble, has been t…
-
CLINICAL_TRIALS research · 2016-06-22Clinical Trial Update: Orthotics and Parkinson's Disease: The Acute and Long-term Effects of Increased Somatosensory Feedback [NA]
Clinical trial update on orthotics providing increased somatosensory feedback for Parkinson disease; the study's status is currently unknown…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects [Phase 1]
Phase 1 pharmacokinetic study of BIA 9-1067 in healthy Japanese and Caucasian subjects; results posted in 2016.